| Phase 4 |
| NCT07744698 |
Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer… |
Squamous Non-Small Cell Lung Cancer sqNSCLC |
Recruiting |
| Phase 2 |
| NCT06437353 |
Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib… |
Ovarian Cancer |
Recruiting |
| NCT06714708 |
Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy… |
NSCLC |
Recruiting |
| NCT06838208 |
Tislelizumab Combined With Chemotherapy and Relayed Radiotherapy in First-line Treatment… |
Extensive-stage Small Cell Lung Cancer (ES-SCLC) |
Recruiting |
| NCT07330596 |
QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC |
NSCLC (Advanced Non-small Cell Lung Cancer) |
Recruiting |
| NCT06973343 |
Sintilimab Plus Bevacizumab and Chemotherapy in MSS/pMMR Colorectal With no Liver… |
Colorectal Cancer Metastatic |
Not Yet Recruiting |
| NCT07014215 |
PD-1 Combined With Bevacizumab and PCSK-9 Inhibitor in Patients With Advanced NSCLC Who… |
NSCLC (Advanced Non-small Cell Lung Cancer) |
Not Yet Recruiting |
| NCT06973330 |
Sintilimab Plus Apatinib and SOX as First-line Treatment in Patients With AFP Gastric or… |
AFP Gastric or Gastroesophageal Junction Adenocarcinoma |
Not Yet Recruiting |
| NCT07047443 |
SHR-1811 Combined With Carboplatin in the Treatment of Advanced Breast Cancer With HER2… |
Breast Cancer |
Not Yet Recruiting |
| NCT07197697 |
A Phase II Exploratory Study of Iparomlimab and Tuvonralimab Combined With Chemotherapy… |
Breast Cancer |
Not Yet Recruiting |
| NCT07299890 |
An Exploratory Study of Pertuzumab and Trastuzumab in Combination With Palbociclib and… |
Breast Cancer |
Not Yet Recruiting |
| NCT07627321 |
Becotatug Vedotin Combined With Pucotenlimab ± Radiotherapy as First-Line Treatment for… |
NSCLC (Advanced Non-small Cell Lung Cancer) |
Not Yet Recruiting |
| NCT07661173 |
A Prospective Study of Firmonertinib as First-line Adaptive Therapy Guided by Dynamic… |
Non Small Cell Lung Cancer |
Not Yet Recruiting |
| Phase 1/2 |
| NCT06395844 |
Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy… |
Ovarian Cancer |
Recruiting |
| NCT06884345 |
METR-NK Cells in Combination With Anti-angiogenic Neoadjuvant Therapy for Advanced… |
Ovarian Cancer |
Active, Not Recruiting |
| NCT07096583 |
An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During… |
Ovary Cancer |
Active, Not Recruiting |
| Not specified |
| NCT07350629 |
Noninvasive Real-Time Arterial Waveform Monitoring for Cardiovascular Disease Assessment |
Aortic Regurgitation Disease |
Recruiting |
| NCT07195084 |
To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage… |
Non-Small Cell Lung Cancer |
Recruiting |
| NCT07371871 |
A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined… |
Advanced Gastric Cancer |
Not Yet Recruiting |
| NCT07623226 |
Super-Resolution Ultrasound Imaging for Assessing Response to Neoadjuvant Chemotherapy in… |
Breast Cancer |
Not Yet Recruiting |